The ESH 4th Translational Research Conference: Chronic Lymphocytic Leukaemia proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field. The presentation of new data is encouraged, as well as spirited debates on how to use this knowledge to the future of CLL therapy.
This translational research conference fosters scientific exchange between laboratory scientists and clinicians working on translational CLL research worldwide. It provides opportunities for education and international networking to basic and clinical scientists, including those still in-training.
A first-class selection of international speakers will guarantee the highest quality of science and a summary of the most recent developments in the biology and therapy of CLL.